Yes
No
About Moody's
Careers
Regulatory Affairs
Terms of Use
Contact Us
About Moody's
Company Overview
Investor Relations
Media Relations
Corporate Social Responsibility
GO
There are too many sessions currently in use on this account
Log In
Cancel
Research & Ratings
Overview
Ratings News
Rating Methodologies
Ratings Performance
Regulatory Affairs
Ratings Disclosures
Requests for Comment
Code of Professional Conduct
Sector in Depth
Market Segment
Corporates
Financial Institutions
Insurance
Structured Finance
Managed Investments
Infrastructure & Project Finance
Sovereign & Supranational
Sub-Sovereign
U.S. Public Finance
Region
North America
Latin America & Caribbean
Europe, Middle East & Africa
Asia Pacific
Research Type
Issuer Research
Sector Research
Methodology
Political / Economic Group
Emerging Markets
European Union
Asia-Pacific Economic Cooperation (APEC)
Association of Southeast Asian Nations (ASEAN)
Commonwealth of Independent States (CIS)
Eurozone
Gulf Cooperation Council
Mercosur
Organisation for Economic Co-operation and Development (OECD)
The Commercial Group
How to Get Rated
Ratings Definitions
Products & Solutions
Overview
Moody's Analytics
Moody’s Securitization Tools
Moody's Advisory Services
Moody's Economy.com
Learning Solutions and Certifications
Moody’s Bureau van Dijk
Solutions
Asset and Liability Management Solutions
Credit Origination Solutions
Credit Risk Solutions
Data Solutions
Economic Solutions
Insurance Solutions
Investment & Pensions Solutions
Learning Solutions and Certifications
Portfolio Management Solutions
Regulatory and Accounting Solutions
Structured Finance Solutions
Access Products
Credit Risk Calculator
Credit Transition Model
Credit Trends
CreditEdge®
Default Recovery Database (DRD)
Default Risk Service - Structured
Fund Monitoring
Market Implied Ratings (MIR®)
Moody's Financial Metrics™
Moody's Project Finance Scorecard
Moody's Quantitative Ratings Estimator (QRATE)
Municipal Financial Ratio Analysis
Ratings Interactive
RiskCalc™
News & Events
Overview
Ratings News
Events
Training Events
Topics
Log In
Register
Log In
Please log in for full access to your permissions. Password is case sensitive.
User Name:
Password:
Automatically log me in when I return
Log In
Forgot your Username or Password?
Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can
continue to Search Results for
""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
You Browsed By:
COUNTRY/JURISDICTION
Israel
(Remove)
STATE / PROVINCE
Pennsylvania
(Remove)
GO
You Searched For:
Refine by:
MARKET SEGMENT
Corporates (45)
Financial Institutions (4)
Funds & Asset Management (2)
Infrastructure & Project Finance (1)
Insurance (1)
Sovereign & Supranational (2)
Structured Finance (4)
Sub-Sovereign (2)
U.S. Public Finance (3)
Show All
REGION
North America (48)
Latin America & Caribbean (37)
Europe, Middle East & Africa (48)
Asia Pacific (7)
Global (1)
Show All
CREDIT QUALITY
Investment Grade (15)
Leveraged (46)
Show All
RESEARCH TYPE
Issuer Research (5)
Ratings & Assessments News (40)
Sector Research (3)
Show All
ORGANIZATION ROLE
Servicer (1)
Show All
SPECIALIZED SITUATION
Diversified (1)
Finance Conduit (2)
Government Related Issuers (1)
Holding Companies (2)
Show All
LANGUAGE
English (47)
Show All
POLITICAL/ECONOMIC GROUP
Emerging Markets (5)
Asia-Pacific Economic Cooperation (APEC) (48)
Association of Southeast Asian Nations (ASEAN) (5)
Commonwealth of Independent States (4)
Economic and Monetary Community of Central Africa (CEMAC) (2)
European Union (26)
Eurozone (26)
Gulf Cooperation Council (4)
Mercosur (4)
Organisation for Economic Co-operation and Development (OECD) (48)
West African Economic and Monetary Union (UEMOA) (2)
Show All
RELATED INFORMATION
UPCOMING EVENTS
More >>
RELATED PRODUCTS
More >>
KEY CONTACTS
Israel - Pennsylvania
Section Overview
Highlights
Research
Organizations
Please refine your search by
Market Segment
to get corresponding
Activity
and
Watchlist
View All
Date
Document Type
Title
Issuer/Entity
17 Dec 2023
Rating Action
Moody's affirms Teva's Ba2 ratings; outlook stable
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
27 Jul 2023
Announcement of Periodic Review
Moody's announces completion of a periodic review for a group of Pharmaceutical issuers
AbbVie Inc.
Alkermes, Inc.
Alvogen Pharma ...
Amgen Inc.
Amneal Pharmace...
ANI Pharmaceuti...
Azurity Pharmac...
Bausch + Lomb C...
Bausch Health A...
Bausch Health C...
...
04 Oct 2022
Announcement of Periodic Review
Moody's announces completion of a periodic review for a group of Pharmaceutical issuers
AbbVie Inc.
Akorn Operating...
Alkermes, Inc.
Alvogen Pharma ...
Amgen Inc.
Amneal Pharmace...
ANI Pharmaceuti...
Azurity Pharmac...
Bausch + Lomb C...
Bausch Health A...
...
15 Dec 2021
Rating Action
Moody's affirms Teva's Ba2 ratings; outlook revised to stable
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
08 Nov 2021
Announcement of Periodic Review
Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd
Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
15 Dec 2020
Announcement of Periodic Review
Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd
Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
07 Apr 2020
Rating Action
Moody's affirms Teva's Ba2 CFR; upgrades liquidity rating to SGL-2
Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
14 Jan 2020
Announcement of Periodic Review
Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd
Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
14 Aug 2019
Rating Action
Moody's affirms Teva's Ba2 CFR; outlook revised to negative
Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
15 Feb 2019
Announcement of Periodic Review
Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd
Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry
